Burkhard Greve

3.7k total citations
101 papers, 2.7k citations indexed

About

Burkhard Greve is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Burkhard Greve has authored 101 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 25 papers in Oncology and 25 papers in Cell Biology. Recurrent topics in Burkhard Greve's work include Proteoglycans and glycosaminoglycans research (24 papers), Cancer Cells and Metastasis (16 papers) and Glycosylation and Glycoproteins Research (13 papers). Burkhard Greve is often cited by papers focused on Proteoglycans and glycosaminoglycans research (24 papers), Cancer Cells and Metastasis (16 papers) and Glycosylation and Glycoproteins Research (13 papers). Burkhard Greve collaborates with scholars based in Germany, Egypt and Italy. Burkhard Greve's co-authors include Martin Götte, Ludwig Kiesel, Sherif Ibrahim, Hans Theodor Eich, Hebatallah Hassan, Björn Kemper, Reinhard Kelsch, Nancy Adriana Espinoza‐Sánchez, W. Göhde and Mohamed El‐Shinawi and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Burkhard Greve

98 papers receiving 2.7k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Burkhard Greve	1.3k	668	589	475	391	101	2.7k
László Damjanovich	762 0.6×	321 0.5×	295 0.5×	235 0.5×	613 1.6×	72	2.2k
Marius Nap	915 0.7×	733 1.1×	330 0.6×	224 0.5×	370 0.9×	68	2.6k
Josep Castellví	1.7k 1.4×	1.0k 1.5×	838 1.4×	201 0.4×	456 1.2×	109	3.6k
Viola Heinzelmann‐Schwarz	1.9k 1.5×	1.8k 2.7×	1.0k 1.7×	274 0.6×	848 2.2×	120	4.2k
Rodrigo Chuaqui	2.4k 1.9×	721 1.1×	817 1.4×	184 0.4×	265 0.7×	55	3.8k
Honami Naora	2.2k 1.8×	864 1.3×	693 1.2×	265 0.6×	848 2.2×	90	3.7k
János L. Tanyi	1.9k 1.5×	1.7k 2.5×	720 1.2×	196 0.4×	887 2.3×	113	3.9k
Claudine Rancourt	2.2k 1.7×	1.0k 1.5×	472 0.8×	196 0.4×	964 2.5×	59	3.6k
Cécile Le Page	1.2k 1.0×	1.1k 1.7×	567 1.0×	157 0.3×	995 2.5×	62	3.1k
Helmut Schaider	1.5k 1.2×	1.1k 1.6×	353 0.6×	250 0.5×	731 1.9×	82	2.9k

Countries citing papers authored by Burkhard Greve

Since Specialization

Citations

This map shows the geographic impact of Burkhard Greve's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Burkhard Greve with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Burkhard Greve more than expected).

Fields of papers citing papers by Burkhard Greve

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Burkhard Greve. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Burkhard Greve. The network helps show where Burkhard Greve may publish in the future.

Co-authorship network of co-authors of Burkhard Greve

This figure shows the co-authorship network connecting the top 25 collaborators of Burkhard Greve. A scholar is included among the top collaborators of Burkhard Greve based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Burkhard Greve. Burkhard Greve is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Greve, Burkhard, et al.. (2025). Role of syndecan-4 in angiogenesis and vasculogenic mimicry in triple negative breast cancer cells. Matrix Biology. 136. 127–133. 3 indexed citations

Korsching, Eberhard, Nancy Adriana Espinoza‐Sánchez, Ezequiel M. Fuentes‐Pananá, et al.. (2025). Musashi inhibitor Ro 08–2750 attenuates triple-negative breast cancer cell proliferation and migration and acts as a novel chemo- and radiosensitizer. Biomedicine & Pharmacotherapy. 186. 118002–118002.

Troschel, Fabian M., Nancy Adriana Espinoza‐Sánchez, Maryam Rezaei, et al.. (2024). Antioxidants Hydroxytyrosol and Thioredoxin-Mimetic Peptide CB3 Protect Irradiated Normal Tissue Cells. Antioxidants. 13(8). 961–961. 2 indexed citations

Espinoza‐Sánchez, Nancy Adriana, Björn Kemper, Hans Theodor Eich, et al.. (2023). Dysregulated Stem Cell Markers Musashi-1 and Musashi-2 are Associated with Therapy Resistance in Inflammatory Breast Cancer. Archives of Medical Research. 54(6). 102855–102855. 6 indexed citations

Espinoza‐Sánchez, Nancy Adriana, Fabian M. Troschel, Burkhard Greve, & Martin Götte. (2023). Proteoglycan Expression Studied by MicroRNAs. Methods in molecular biology. 2619. 273–292. 1 indexed citations

Troschel, Fabian M., Eduardo Vadillo, Hans Theodor Eich, et al.. (2022). Enzymatic Digestion of Cell-surface Heparan Sulfate Alters the Radiation Response in Triple-negative Breast Cancer Cells. Archives of Medical Research. 53(8). 826–839. 5 indexed citations

Espinoza‐Sánchez, Nancy Adriana, Mohamed A. Badawy, Burkhard Greve, et al.. (2021). Small extracellular vesicle-encapsulated miR-181b-5p, miR-222-3p and let-7a-5p: Next generation plasma biopsy-based diagnostic biomarkers for inflammatory breast cancer. PLoS ONE. 16(4). e0250642–e0250642. 32 indexed citations

Ibrahim, Sherif, Ramy Gadalla, Eslam A. Elghonaimy, et al.. (2017). Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways. Molecular Cancer. 16(1). 57–57. 208 indexed citations

Fortmann, Thomas, Burkhard Greve, Daniel M. Prevedello, et al.. (2016). 5-ALA Fluorescence in Native Pituitary Adenoma Cell Lines: Resection Control and Basis for Photodynamic Therapy (PDT)?. PLoS ONE. 11(9). e0161364–e0161364. 16 indexed citations

10.

Viola, Manuela, Evgenia Karousou, Ilaria Caon, et al.. (2016). MDA-MB-231 breast cancer cell viability, motility and matrix adhesion are regulated by a complex interplay of heparan sulfate, chondroitin−/dermatan sulfate and hyaluronan biosynthesis. Glycoconjugate Journal. 34(3). 411–420. 26 indexed citations

11.

Reinbold, Rolland, Sebastian Daniel Schäfer, Ludwig Kiesel, et al.. (2016). microRNA miR-200b affects proliferation, invasiveness and stemness of endometriotic cells by targeting ZEB1, ZEB2 and KLF4. Reproductive BioMedicine Online. 32(4). 434–445. 71 indexed citations

12.

Spaniol, Kristina, Marco Metzger, Mathias Roth, et al.. (2015). Engineering of a Secretory Active Three-Dimensional Lacrimal Gland Construct on the Basis of Decellularized Lacrimal Gland Tissue. Tissue Engineering Part A. 21(19-20). 2605–2617. 28 indexed citations

13.

Bernemann, Christof, Christian Rückert, Georg Hempel, et al.. (2014). Influence of secreted frizzled receptor protein 1 (SFRP1) on neoadjuvant chemotherapy in triple negative breast cancer does not rely on WNT signaling. Molecular Cancer. 13(1). 174–174. 48 indexed citations

14.

Sterzing, Florian, Thomas Brunner, Iris Ernst, et al.. (2014). Stereotactic body radiotherapy for liver tumors. Strahlentherapie und Onkologie. 190(10). 872–881. 79 indexed citations

15.

Greve, Burkhard, Cornelia Schneider, Andreas N. Schüring, et al.. (2013). MicroRNA miR-145 inhibits proliferation, invasiveness, and stem cell phenotype of an in vitro endometriosis model by targeting multiple cytoskeletal elements and pluripotency factors. Fertility and Sterility. 99(5). 1346–1355.e5. 85 indexed citations

16.

Ibrahim, Sherif, Hebatallah Hassan, Reinhard Kelsch, et al.. (2013). Syndecan-1 (CD138) Modulates Triple-Negative Breast Cancer Stem Cell Properties via Regulation of LRP-6 and IL-6-Mediated STAT3 Signaling. PLoS ONE. 8(12). e85737–e85737. 95 indexed citations

17.

Agelopoulos, Konstantin, Burkhard Greve, Hartmut Schmidt, et al.. (2010). Selective regain of egfr gene copies in CD44+/CD24-/lowbreast cancer cellular model MDA-MB-468. BMC Cancer. 10(1). 78–78. 19 indexed citations

18.

Cassens, U., W. Göhde, Walter Sibrowski, et al.. (2010). An improved PCR method for detection of HIV-1 proviral DNA of a wide range of subtypes and recombinant forms circulating globally. Journal of Virological Methods. 172(1-2). 22–26. 5 indexed citations

19.

Greve, Burkhard, Niels Wedemeyer, U. Hacker-Klom, et al.. (2005). Evidence for predictive validity of blood assays to evaluate individual radiosensitivity. International Journal of Radiation Oncology*Biology*Physics. 64(1). 242–250. 14 indexed citations

20.

Greve, Burkhard, et al.. (2003). High-Grade Loss of Leukocytes and Hematopoietic Progenitor Cells Caused by Erythrocyte-Lysing Procedures for Flow Cytometric Analyses. Journal of Hematotherapy & Stem Cell Research. 12(3). 321–330. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact